This multi-receptor approach is intended to enhance metabolic regulation by combining appetite suppression, energy expenditure, and glucose control within a single compound
Patients should also carry alcohol swabs, sharps containers, and any necessary supplies
A program like Weight Watchers can offer support, coaching, and a clear plan
Current clinical evidence for possible antidepressant effects of GLP-1R agonists Depression is often comorbid with metabolic disorders such as T2DM and obesity and many antidiabetic drugs, which often display neuroprotective and immunomodulatory effect, have demonstrated antidepressant properties in clinical trials
Early research in both animals and humans suggests that these treatments may help reduce alcohol and other substance use, commented the reviews lead researcher, Lorenzo Leggio, M.D., Ph.D
Key Takeaways North America led the GLP-1 market by holding a major share of 57% in 2025